Alfa Chemistry Releases Carbomer Series Products for Cosmetics and Personal Care Products Manufacturing

ResultsCX Named ‘Disruptor’ in Avasant’s Contact Center Business Process Transformation 2023-2024 RadarView™ Assessment

Clearwater and 1stResponder Partner to Expand Cybersecurity Incident Response within Clearwater's Managed Security Service Provider (MSSP) Portfolio

From Ordinary to Extraordinary: CD Formulation's Remarkable Food Ingredient Launch

MultiOmic Health and Queen’s University Belfast join forces to transform diabetic kidney disease diagnosis

London, UK, 7th February 2024 / Sciad Newswire / MultiOmic Health, an artificial intelligence (AI)-enabled drug discovery company, is embarking on a collaborative project with the Centre for Public Health at Queen’s University Belfast (QUB) in Northern Ireland to develop data-driven diagnostic tools for Diabetic Kidney Disease (DKD). The two-year project is partially funded by a grant recently awarded to MultiOmic Health under Innovate UK’s £20 million Advancing Precision Medicine programme, supporting industry-led research projects to enable more accurate diagnosis and treatment stratification within the UK National Health Service (NHS).

Alfa Chemistry Catalysts: Porphyrin Ligands, Phthalocyanine Ligands Are Newly Released for the Science Community

Game-Changing ‘Audit Trail Review’ Application Secures ACDM 2024 Awards Nomination for CluePoints

Game-Changing ‘Audit Trail Review’ Application Secures ACDM 2024 Awards Nomination for CluePoints RBQM Leader Shortlisted for Accolade for Innovation in the Management of Clinical Data

CD Formulation Shows the Ability of Coated Microneedle Preparation Technology for Novel Drug Delivery

Verisense Health Adopts Datavant’s Data Connectivity Platform to Expand its Digital Health Panel’s RWD Sources

Datavant’s privacy-preserving record linkage technology will allow Verisense Health’s digital health data to generate richer patient insights.

Azenta Launches the BioArc Ultra, a Breakthrough, Automated Solution for Efficient, Eco-Friendly Ultracold Sample Management

Azenta, Inc has announced the launch of the BioArc™ Ultra, a breakthrough, automated solution for high-density, eco-friendly ultracold sample management, designed to provide a new level of performance.

Showcase on lab automation instruments and consumables on display at SLAS2024 International Conference and Exhibition

Azenta Life Sciences has announced that it will display a range of productivity-enhancing consumables, instruments, and automated sample storage products at SLAS 2024 in Boston, USA from February 5 - 7.

Integrated DNA Technologies and Element Biosciences Accelerate Next Generation Sequencing Workflows for Element’s AVITI™ System

Integrated DNA Technologies and Element Biosciences are bolstering its partnership to equip AVITI users with differentiated NGS tools.

SPT Labtech Appoints New Chief Commercial Officer

First Patient Dosed with LIXTE’s LB-100 and GSK’s Immunotherapy Dostarlimab-gxly in Ovarian Clear Cell Carcinoma Trial

Lixe Biotechnology announced the dosing of the first patient in its Phase 1b/2 clinical trial to assess the efficacy of its LB-100 lead molecule with GSK's PD-1-blocking monoclonal antibody, dostarlimab-gxly, in the treatment of ovarian clear cell carcinoma.

Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies in the Space Streamline Clinical Trials

Lindus Health Introduces Bespoke “All-In-One CRO for Digital Therapeutics” Solution to Companies in the Space Streamline Clinical Trials

Effortless Measurement of All Four NADs and Glutathione for Laboratories

NADMED has announced an innovative technology designed for effortless extracting and measuring all four NADs and two glutathiones.

AppOmni Harnesses Google Data Center in Australia to Address Regional Demand for Specialised SaaS Security Solutions

AppOmni, the pioneer of SaaS security posture management (SSPM), proudly announces the establishment of a new data centre in Sydney, Australia, hosted by Google Cloud Platform (GCP). This new initiative brings AppOmni’s comprehensive SaaS security solutions to any organisation—private or public—required to comply with Australia’s data sovereignty regulations, including the Privacy Act and the Australian Privacy Principles. As AppOmni continues its global expansion efforts, Australia remains a strategic location for the company. The new data centre helps address a growing need in the APAC region to counter sophisticated threats targeting SaaS applications. These concerns are echoed by the 25% of Fortune 100 companies that already trust AppOmni to secure their SaaS ecosystems.

Watson-Marlow to demonstrate latest fluid path technologies at MD&M West

Devens, MA, US / 30th January 2023 / Sciad Newswire / Watson-Marlow Fluid Technology Solutions (WMFTS), a leader in peristaltic pumps and associated fluid path technologies, will showcase its diverse product range specially designed for medical devices and diagnostic instruments at MD&M West in Anaheim, CA, from February 6-8.

ZeOmega Partners With Datycs to Digitize Faxed Documents and Automate Healthcare Data Workflows

This collaboration allows payers to make processes such as prior authorization more efficient; especially critical given the new requirements for faster turnaround times. Digitizing faxed documents and applying technologies such as AI and NLP to mine data cuts back on manual steps, reducing administrative burden and costs.

Currax Pharmaceuticals Announces First Patient Screened into the INFORMUS Cardiovascular Outcomes Trial

Currax Pharmaceuticals announces the first patient screened and accepted into the CONTRAVE® INFORMUS Cardiovascular Outcomes Trial (NB-CVOT3).